Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Relmada Therapeutics (RLMD) Return on Equity (2016 - 2026)

Relmada Therapeutics has reported Return on Equity over the past 2 years, most recently at 0.01% for Q1 2014.

  • Quarterly Return on Equity changed N/A to 0.01% in Q1 2014 from the year-ago period, while the trailing twelve-month figure was 0.01% through Feb 2014, changed N/A year-over-year, with the annual reading at 0.39% for FY2013, N/A changed from the prior year.
  • Return on Equity was 0.01% for Q1 2014 at Relmada Therapeutics, down from 0.02% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.04% in Q2 2013 and troughed at 0.01% in Q1 2014.